Skip to main content
. 2013 Apr 2;8(4):e60348. doi: 10.1371/journal.pone.0060348

Table 2. List of excluded reviews with reasons.

Reference (A–Z) Reason for exclusion
Beigel J et al. Antiviral Res. 2008 [49] no systematic literature search, narrative review
Bettis R et al. Clin Drug Investig. 2006 [50] no systematic literature search, narrative review
Bijl D. Int J Risk Saf Med. 2011 [51] no systematic literature search, narrative review
Burch J et al. Lancet Infect Dis. 2009 [23] Journal publication of Health Technology Appraisal of Burch et al. [8]
Chidiac C. Rev Prat. 2008 [52] no systematic literature search, narrative review
Clark NM et al. Semin Respir Crit Care Med. 2011 [53] no systematic literature search, narrative review
Dutkowski R. J Antimicrob Chemother. 2010 [54] no systematic literature search, narrative review
Ferraris O et al. Pathol Biol (Paris). 2010 [55] no systematic literature search, narrative review
Freemantle N et al. BMJ. 2009 [56] no systematic literature search, narrative review; no RCTs included, evidence based on observational studies
Health Technology Assessment, 2010; HTA-32010000424 [57] older version of Turner et al., replaced by Burch et al. [8] and Tappenden et al. [18]
Heneghan CJ. Health Technology Assessment programme, 2011, HTA-32011001126 [58] only a protocol version, final version not available
Hernán MA et al. Clin Infect Dis. 2011 [34] no systematic literature search, no critical quality appraisal for the included RCTs
Holzgrabe U. Pharm Unserer Zeit. 2011 [59] no systematic literature search, narrative review
Jamieson B et al. Can Fam Physician. 2009 [60] no systematic literature search, narrative review
Jefferson T et al. Cochrane Syst Rev. 2006 [61] not the most recent publication of the same research group (Jefferson et al. 2012 [10])
Jefferson T et al. Lancet. 2006 [62] journal publication of Cochrane Syst. Rev. Jefferson et al. 2006 [61]
Jefferson T et al. BMJ. 2009 [63] evidence included in Cochrane Syst. Rev. Jefferson et al. 2010 [64]
Jefferson T et al. Cochrane Syst Rev. 2010 [64] not the most recent publication of the same research group (Jefferson et al. 2012) (withdrawn)
Jefferson T et al. Health Technol Assess. 2010 [65] same evidence included in the Cochrane Syst. Rev. of Jefferson et al. 2010 [64]
Jefferson T et al. Cochrane Syst Rev: 2011 [66] only a protocol version, final version not available
Jones M et al. Expert Opin Drug Saf. 2006 [67] Evidence included in the Cochrane syst. Rev. of Jefferson et al. 2006 [61]
Klebe G et al. Pharm Unserer Zeit. 2011 [68] no systematic literature search, narrative review
Lee N et al. Antivir Ther. 2012 [69] no systematic literature search, narrative review
Lynch JP et al. Semin Respir Crit Care Med. 2007 [70] no systematic literature search, narrative review
Mallia P et al. Int J Chron Obstruct Pulmon Dis. 2007 [71] no systematic literature search, narrative review
Matheson NJ et al. Cochrane Syst Rev. 2007 [72] not the most recent publication of the same research group (Wang et al. [17], Jefferson et al. 2012 [10])
McCullers JA. Antivir Ther. 2011 [73] no systematic literature search, narrative review
Moscona A. Annu Rev Med. 2008 [74] no systematic literature search, narrative review
National Institute for Health and Clinical Excellence (NICE), 2009; HTA-32011000098 (TA-168) [40] NICE Technology appraisal guidance based on the systematic review of Burch et al. [8]
National Institute for Health and Clinical Excellence (NICE), 2008; HTA-32011000382 (TA-67) [75] NICE Technology appraisal guidance based on the systematic review of Tappenden P et al. [18]
Nayak JL et al. Pediatr Ann. 2009 [76] no systematic literature search, narrative review
No author. Med Lett Drugs Ther.2006 [77] no systematic literature search, narrative review
No author. Med Lett Drugs Ther. 2009 [78] no systematic literature search, narrative review
No author. Med Lett Drugs Ther. 2012 [79] no systematic literature search, narrative review
Nüesch R. Ther Umsch. 2007 [80] no systematic literature search, narrative review
Oxford JS. Influenza Other Respi Viruses. 2007 [81] no systematic literature search, narrative review
Preziosi P. Expert Opin Pharmacother. 2011 [82] no systematic literature search, narrative review
Ruf BR et al. Dtsch Med Wochenschr. 2008 [83] no systematic literature search, narrative review
Ruf BR et al. Infection Control & Hospital Epidemiology. 2009 [84] no systematic literature search, narrative review
Salzberger B. Internist (Berl). 2006 [85] no systematic literature search, narrative review
Schirmer P et al. Expert Opin Drug Saf. 2009 [86] no systematic literature search, narrative review
Shun-Shin M et al. BMJ. 2009 [87] not the most recent publication of the same research group (Wang et al. [17], Jefferson et al, 2012 [10])
Smith JR et al. Adv Ther. 2011 [88] no systematic literature search, narrative review
Tambyah PA. Respirology. 2008 [89] no systematic literature search, narrative review
Tappenden P et al. Health Technology Assessment, 2009; HTA-32008100360 [90] replaced by the systematic review of Tappenden P et al. [18]
Toovey S et al. Drug Saf. 2008 [91] no systematic literature search, narrative review
Townsend KA et al. Pharmacotherapy. 2006 [92] no systematic literature search, narrative review
Tullu MS. J Postgrad Med. 2009 [93] no systematic literature search, narrative review
Wang K et al. Cochrane Database Syst Rev. 2012 [94] replaced by the systematic review of Wang et al. [17]
Wesseling G. Int J Chron Obstruct Pulmon Dis. 2007 [95] no systematic literature search, narrative review
Whitley RJ. Expert Opin Drug Metab Toxicol. 2007 [96] no systematic literature search, narrative review
Yang Ming et al. Cochrane Syst Rev: Protocols 2010 [97] only a protocol version, final version not available
Yang Ming et al. Cochrane Syst Rev: Protocols 2010 [98] only a protocol version, final version not available